跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,106 条关于
“hereditary transthyretin amyloidosis”
全部
2,106
临床试验
1,522
药物
44
机构
4
资讯
536
去年
EU Approves WAINZUA (Eplontersen) for Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
去年
Swissmedic Authorizes Tegsedi for Hereditary Transthyretin Amyloidosis
去年
Eplontersen (Wainzua) Recommended in England and Wales for Hereditary Transthyretin Amyloidosis
去年
FDA Clears AI-Powered Ultrasound Software EchoGo® Amyloidosis for Enhanced Cardiac Amyloidosis Detection
去年
Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection
去年
Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection
去年
FDA Accepts Alnylam's Vutrisiran sNDA for ATTR Amyloidosis with Cardiomyopathy
2年前
CRISPR Technology Shows Promise Across Diverse Clinical Applications
去年
FDA Accepts Alnylam's Vutrisiran Application for ATTR Amyloidosis with Cardiomyopathy
去年
EMA Recommends Approvals for Novel Therapies Targeting Cancer, Hemophilia, and Neurological Disorders
第 1 页，共 54 页
上一页
下一页
